Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Oral Oncology|August 18, 2018
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neckJared Weiss, Jill Gilbert, Allison Mary Deal, et al.
Practical Radiation Oncology|March 29, 2014
Patterns of local failure for sinonasal malignanciesDavid V Fried, Adam M Zanation, Benjamin Huang, et al.
Advances in Radiation Oncology|September 11, 2018
Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinomaGreg D Judy, Rebecca Green, Shannon L Aumer, et al.
American Journal of Clinical Oncology|March 12, 2021
Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell CarcinomaJessica M Wilson, Catherine Lumley, Xianming Tan, et al.
The Laryngoscope|November 10, 2020
Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer OutcomesNicholas R Lenze, Douglas Farquhar, Siddharth Sheth, et al.
The Laryngoscope|October 1, 2025
Perioperative Antibiotics in Sialendoscopy: A Retrospective Cohort StudyKelsey E Lacourrege, Febronia Morcos Mansour, Victoria Fonseca, et al.
Oral Oncology|June 23, 2021
Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinomaNicholas R Lenze, Douglas R Farquhar, Siddharth Sheth, et al.
Head & Neck|July 4, 2020
Access to preventive care services and stage at diagnosis in head and neck cancerDouglas R Farquhar, Nicholas R Lenze, Maheer M Masood, et al.
Translational Cancer Research|October 21, 2024
Comparison of surgical margins and adjuvant therapy for head and neck cancer by hospital typeDouglas R Farquhar, Nicholas R Lenze, Jason Tasoulas, et al.
Head & Neck|September 11, 2020
Age and risk of recurrence in oral tongue squamous cell carcinoma: Systematic reviewNicholas R Lenze, Douglas R Farquhar, Christina Dorismond, et al.
Pageof 6